Cooperative Agreement 72062118CA00002
Award Date
8/7/18
Completion Date
12/31/22
Dollars Obligated
$21M
Federal Agency
US Mission in Tanzania
Federal Grant Program
98.001
Assistance Type
Cooperative Agreement
Place of Performance
Tanzania
Similar Awards
This federal Cooperative Agreement award, funded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas program (CFDA 98.001), aims to increase the utilization of quality HIV prevention and treatment services in Tanzania through community-led monitoring activities. The $2.1 million award, with a performance period from January 1, 2025 to December 31, 2029, will be implemented by the National Council of People Living with HIV/AIDS (NACOPHA)...
This Cooperative Agreement award from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas program (CFDA 98.001) provides $400,000.00 in funding to the University of Sciences, Techniques and Technologies of Bamako (Usttb) in Mali. The purpose of this award is to conduct entomological surveillance, insecticide-treated bed net durability monitoring, and routine monitoring of antimalarial drug efficacy and detection of resistance activities. The...
This Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Global AIDS program (CFDA 93.067) provides $1,065,324 to the President's Office Regional Administration and Local Government (PORALG) in Tanzania. The project will accelerate the implementation of health policy strategies for HIV/AIDS treatment services over a 5-year period from September 30, 2024 to September 30, 2029. The funding will support technical assistance, service delivery, and...
This $7,900,000 Cooperative Agreement award, funded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program, supports the strengthening of Tanzania's capacities to develop, validate, and implement interventions to prevent, detect, and respond to emerging infectious diseases. The award, effective from January 6, 2025 to January 5, 2030, is being administered by the Center for International Health, Education and...
This $3,850,000 Project Grant awarded on September 18, 2023 by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program will support Maisha Healthcare, Inc., a for-profit, woman-owned small business, in scaling a digital approach to targeted malaria treatment in Uganda over a 3-year period. The funded activities are intended to promote long-term and equitable economic growth and advance U.S. foreign policy objectives globally,...
This $2,580,000 cooperative agreement, awarded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas program (CFDA 98.001), will deliver quality, high-impact malaria control and prevention services through public and community channels in The Gambia. The five-year project, running from November 2024 to November 2029, aims to contribute to a measurable reduction in malaria mortality and morbidity in alignment with The Gambia's national malaria...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a longitudinal cohort study to examine the impact of early childhood malaria prevention interventions on malaria risk in school-age children in Ghana. The study, titled "IMPACT OF EARLY CHILDHOOD MALARIA PREVENTION ON MALARIA RISK AT SCHOOL ENTRY (ERASE)", will evaluate the epidemiological and...
The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $10,151,871 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the University of California, San Francisco (UCSF) to lead the Alliance for Country-Led Control of the HIV Epidemic by Leveraging Efficient Resource Allocation to Achieve Equity (ACCELERATE) consortium. This 4-year award, effective September 30, 2024, aims to promote sustainable, data-driven, and equitable HIV/AIDS programs in Kenya, Uganda,...
The U.S. Agency for International Development (USAID) awarded $600,000 under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) federal grant program to support a data collection and analysis system for detailed documentation of a simplified protocol for treatment of acute malnutrition (OPTIMA), including cost-effectiveness analysis, and to contribute to advocacy around simplified nutrition approaches. The Alliance For International Medical Action will deliver these services in...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $702,204 Cooperative Agreement under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the London School of Hygiene and Tropical Medicine (LSHTM) to conduct research on complex malaria in India. The key products and services to be delivered through this 5-year project include: Monitoring the changing epidemiology of malaria in Odisha, India through a 4-year community-based cohort study to...